Loquat (Eriobotrya japonica)

Loquat (Eriobotrya japonica) leaf extract contains ursolic acid and corosolic acid as primary bioactives, which inhibit alpha-glucosidase and enhance insulin receptor sensitivity to support blood glucose regulation. Its triterpene and polyphenol content also suppresses airway inflammation by downregulating NF-κB signaling, underpinning its traditional use in respiratory conditions.

Origin & History

Loquat (Eriobotrya japonica) is a small evergreen tree native to central and south-eastern China, now cultivated widely in subtropical regions for its fruit and leaves. The leaves are typically extracted via decoction, water, or ethanol methods to yield polyphenolic-rich extracts, while the fruit is consumed fresh or processed into pulp.

Historical & Cultural Context

Loquat has been used in Traditional Chinese Medicine since the Tang Dynasty (7th century) for diabetes, respiratory issues, inflammation, and digestive aid. In Ayurveda, it balances Pitta and Kapha doshas for similar applications, with Mediterranean and Japanese folk medicine echoing these traditional uses.

Health Benefits

• Blood sugar management: A 2021 double-blind trial (n=60) showed 0.7% HbA1c reduction with standardized leaf extract (moderate evidence)
• Respiratory support: Observational study found 60% of chronic bronchitis patients experienced decreased cough frequency with traditional leaf tea (preliminary evidence)
• Anti-inflammatory effects: Preclinical studies show suppression of IL-6, TNF-α and NF-κB activation (preliminary evidence)
• Skin health: Open-label study showed improvement in dermatitis symptoms within 2 weeks using topical ursolic acid-enriched ointment (preliminary evidence)
• Digestive support: Traditional use for dyspepsia, with potential gut microbiota benefits via bifidobacteria promotion (traditional evidence)

How It Works

Corosolic acid and ursolic acid in loquat leaf extract competitively inhibit intestinal alpha-glucosidase and alpha-amylase enzymes, slowing postprandial glucose absorption and blunting glycemic spikes. Ursolic acid also activates AMPK (AMP-activated protein kinase) signaling in skeletal muscle, promoting GLUT4 translocation to the cell surface and increasing peripheral glucose uptake independent of insulin. Additionally, polyphenolic compounds including chlorogenic acid and epicatechin suppress NF-κB and MAPK inflammatory pathways in bronchial epithelial cells, reducing mucus hypersecretion and pro-inflammatory cytokine release (IL-6, TNF-α).

Scientific Research

Clinical evidence for loquat is limited to small-scale studies, with the most robust being a 2021 double-blind, placebo-controlled trial in India (n=60) showing 0.7% HbA1c reduction in type 2 diabetics. A 2014 randomized trial reported 12% reduction in fasting blood sugar, though sample size was not specified. No PMIDs were provided in the research sources, and no meta-analyses or large RCTs have been conducted.

Clinical Summary

A 2021 randomized double-blind trial (n=60) demonstrated that standardized loquat leaf extract producing approximately 10% ursolic acid reduced HbA1c by 0.7% over 12 weeks in type 2 diabetic patients, representing moderate-quality evidence. An observational study reported that 60% of chronic bronchitis patients using traditional loquat leaf tea experienced reduced cough frequency, though lack of controls limits causal inference. Animal models consistently show dose-dependent reductions in fasting blood glucose at 200–400 mg/kg body weight, but human dose-response data remain sparse. Overall, blood sugar evidence is promising but preliminary; respiratory evidence is largely anecdotal and requires controlled clinical trials before firm conclusions can be drawn.

Nutritional Profile

Loquat fruit (Eriobotrya japonica) per 100g fresh weight: Macronutrients — Calories: ~47 kcal; Carbohydrates: ~12.1g (primarily fructose ~3.5g, glucose ~2.9g, sucrose ~1.8g); Dietary fiber: ~1.7g (mix of soluble pectin ~0.6g and insoluble cellulose); Protein: ~0.43g (low, not a significant source); Fat: ~0.2g. Key Micronutrients — Vitamin A (as beta-carotene): ~76 µg RAE (carotenoids are the dominant micronutrient; bioavailability enhanced by co-consumption with dietary fat); Vitamin C: ~1mg (notably low compared to other fruits); Potassium: ~266mg (meaningful contribution toward daily 4,700mg target); Manganese: ~0.148mg (~6% DV); Magnesium: ~13mg; Calcium: ~16mg; Iron: ~0.28mg (non-heme, bioavailability ~5–12%, enhanced by vitamin C co-ingestion); Phosphorus: ~27mg; Folate: ~14 µg DFE. Bioactive Compounds — Carotenoids: Total carotenoids ~200–800 µg/100g fresh weight, predominantly β-carotene (~45%), β-cryptoxanthin (~30%), and zeaxanthin (~15%); concentrations vary significantly with ripeness and cultivar. Polyphenols: Chlorogenic acid ~15–40mg/100g (primary phenolic acid); epicatechin and procyanidins present at ~5–20mg/100g; quercetin glycosides ~2–8mg/100g. Triterpene acids (primarily in peel): Ursolic acid and oleanolic acid detected at ~0.5–2mg/100g in whole fruit — these are the key anti-inflammatory compounds noted in preclinical NF-κB/IL-6/TNF-α studies; concentrated ~10–20× higher in dried leaf preparations used in clinical extracts. Organic acids: Malic acid (~65% of total acids), citric acid (~20%), tartaric acid (~10%); total titratable acidity ~0.4–0.8g/100g. Pectin: ~0.3–0.6g/100g fresh weight — contributes to soluble fiber content relevant to glycemic modulation noted in HbA1c trial (though trial used leaf extract, not fruit). Bioavailability Notes: Carotenoid absorption is fat-dependent (estimated 3–5× higher bioavailability with 3–5g fat co-ingestion); polyphenol bioavailability is moderate (~15–30% absorption) and subject to gut microbiome metabolism; the HbA1c and respiratory evidence cited derives from leaf extracts standardized to specific triterpene/polyphenol content, not fresh fruit, so direct clinical extrapolation to fruit consumption requires caution. Fruit is a low-calorie, moderate-potassium, carotenoid-rich food with meaningful polyphenol content but limited protein, vitamin C, and fat.

Preparation & Dosage

Clinically studied dosages include: 10 mg corosolic acid daily from standardized leaf extract for 12 weeks (diabetes), leaf extract standardized to 15% corosolic acid for 8 weeks (diabetes), and traditional 5% leaf decoction for respiratory support. No data available for powder forms or other standardizations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cinnamon extract, Gymnema sylvestre, Chromium picolinate, Alpha-lipoic acid, Bitter melon

Safety & Interactions

Loquat leaf extract is generally well tolerated at studied doses (typically 250–500 mg standardized extract daily), with mild gastrointestinal discomfort reported in a small percentage of participants in clinical trials. Individuals taking oral hypoglycemic agents (metformin, sulfonylureas) or insulin should exercise caution, as additive blood-glucose-lowering effects may increase hypoglycemia risk and warrant blood glucose monitoring. Loquat seeds and raw leaves contain amygdalin, a cyanogenic glycoside that releases hydrogen cyanide upon hydrolysis; only properly processed leaf preparations should be consumed, not home-prepared seed decoctions. Safety data in pregnant or breastfeeding women are insufficient to establish a risk profile, and use during pregnancy should be avoided unless supervised by a healthcare provider.